sellModerate cluster of 3
Robert G. Breighner JR sold $100k of SEM
VICE PRESIDENT, COMPLIANCE at SELECT MEDICAL HOLDINGS CORP. 4,989 shares at an average of $19.95, traded Dec 4, 2024, filed Dec 6, 2024.
Warning score
45Value
$100k
4,989 shares
Holdings after
30,356
-14% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +10Trade size$100k at market
- +5Share of holdings soldSold 14% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-028519, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 4, 2024 | SOpen-market sale Common Stock | -4,989 | $19.95 | $100k | 30,356 | Dec 6, 2024 |
Related signals
Other insiders at SELECT MEDICAL HOLDINGS CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | SEMbuy SELECT MEDICAL HOLDINGS CORP | Parvinderjit S. Khanuja director | $315k 21,000 shares | +48% | |
| 35Weak | SELECT MEDICAL HOLDINGS CORP | David S Chernow CEO | $4.0M 225,000 shares | -24% | |
| 80Strong | SELECT MEDICAL HOLDINGS CORP | Robert A Ortenzio EXECUTIVE CHAIRMAN | $74M 3,804,805 shares | -100% | |
| 70Notable | SELECT MEDICAL HOLDINGS CORP | Marilyn B Tavenner director | $675k 32,000 shares | -59% | |
| 25Weak | SELECT MEDICAL HOLDINGS CORP | Robert A Ortenzio EXECUTIVE CHAIRMAN | $1.4M 50,000 shares | -1% | |
| 25Weak | SELECT MEDICAL HOLDINGS CORP | Robert A Ortenzio EXECUTIVE CHAIRMAN | $1.3M 50,000 shares | -1% | |
| 25Weak | SELECT MEDICAL HOLDINGS CORP | Robert A Ortenzio EXECUTIVE CHAIRMAN | $2.7M 100,000 shares | -1% | |
| 25Weak | SELECT MEDICAL HOLDINGS CORP | Robert A Ortenzio EXECUTIVE CHAIRMAN | $2.5M 100,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.